Divi’s Labs Q4 net up 13% to ₹751 cr., declares ₹30 dividend

Generic drugmaker Divi’s Laboratories reported consolidated nett net for March 4th accrued much than 13% to ₹751 crore compared to ₹662 crore a twelvemonth earlier.

The higher nett came connected a consolidated full income of ₹2,986 crore (₹2,671 crore). Foreign speech summation for the 4th was ₹90 crore (₹10 crore).

The progressive pharmaceutical ingredient, intermediates and nutraceutical ingredients shaper has declared a last dividend of ₹30 per equity stock (face worth of ₹2 each) for 2025-26 and fixed July 24 arsenic the grounds date, for the same.

For FY26, the institution posted nett net of ₹2,568 crore (₹2,191 crore) connected a full income of ₹11,067 crore (₹9,712 crore). The forex summation during the fiscal was ₹211 crore (₹48 crore).